DENVER--(BUSINESS WIRE)--May 15, 2006--Corgenix Medical Corporation (OTCBB: CONX - News), a worldwide developer and marketer of diagnostic test kits, reported sales of $1,634,446 for the third fiscal quarter ended March 31, 2006, an increase of 13.2% from the $1,444,553 in sales reported for the quarter ended March 31, 2005. Sales for the nine-month period this year increased 20.5% to $4,850,282 from $4,024,195 for the comparable period in 2005. The continued increase in the Company's sales is primarily attributable to an overall increase in demand for -- and increased acceptance of -- the Company's diagnostic kits.
